Sort   by:  
 Page size 
UnknownPredicting the disease severity in male individuals with ornithine transcarbamylase deficiency.
Not available
S-EPMC9639638 | biostudies-literature
UnknownLong-term effects of medical management on growth and weight in individuals with urea cycle disorders.
Not available
S-EPMC7371674 | biostudies-literature
UnknownASL expression in ALDH1A1<sup>+</sup> neurons in the substantia nigra metabolically contributes to neurodegenerative phenotype.
Not available
S-EPMC8460544 | biostudies-literature
UnknownHuman recombinant arginase enzyme reduces plasma arginine in mouse models of arginase deficiency.
Not available
S-EPMC5007608 | biostudies-literature
UnknownTransatlantic combined and comparative data analysis of 1095 patients with urea cycle disorders-A successful strategy for clinical research of rare diseases.
Not available
S-EPMC7329920 | biostudies-literature
UnknownDe novo variants in H3-3A and H3-3B are associated with neurodevelopmental delay, dysmorphic features, and structural brain abnormalities.
Not available
S-EPMC8651650 | biostudies-literature
UnknownImpact of supplementation with L-citrulline/arginine after liver transplantation in individuals with Urea Cycle Disorders.
Not available
S-EPMC12812261 | biostudies-literature
UnknownImpact of Diagnosis and Therapy on Cognitive Function in Urea Cycle Disorders.
Not available
S-EPMC6692656 | biostudies-literature
UnknownFactors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial.
Not available
S-EPMC11187765 | biostudies-literature
UnknownSeverity-adjusted evaluation of liver transplantation on health outcomes in urea cycle disorders.
Not available
S-EPMC12812259 | biostudies-literature
Sort   by:  
 Page size